TY - JOUR
T1 - Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti–Helicobacter pylori IgG Titers
AU - Lam, Suk Yee
AU - Mommersteeg, Michiel C.
AU - Yu, Bingting
AU - Broer, Linda
AU - Spaander, Manon C.W.
AU - Frost, Fabian
AU - Weiss, Stefan
AU - Völzke, Henry
AU - Lerch, Markus M.
AU - Schöttker, Ben
AU - Zhang, Yan
AU - Stocker, Hannah
AU - Brenner, Hermann
AU - Levy, Daniel
AU - Hwang, Shih Jen
AU - Wood, Alexis C.
AU - Rich, Stephen S.
AU - Rotter, Jerome I.
AU - Taylor, Kent D.
AU - Tracy, Russell P.
AU - Kabagambe, Edmond K.
AU - Leja, Marcis
AU - Klovins, Janis
AU - Peculis, Raitis
AU - Rudzite, Dace
AU - Nikitina-Zake, Liene
AU - Skenders, Girts
AU - Rovite, Vita
AU - Uitterlinden, André
AU - Kuipers, Ernst J.
AU - Fuhler, Gwenny M.
AU - Homuth, Georg
AU - Peppelenbosch, Maikel P.
N1 - Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2022/1
Y1 - 2022/1
N2 - Background & Aims: A genome-wide significant association between anti–Helicobacter pylori (H pylori) IgG titers and Toll-like receptor (TLR1/6/10) locus on 4p14 was demonstrated for individuals of European ancestry, but not uniformly replicated. We re-investigated this association in an updated genome-wide association study (GWAS) meta-analysis for populations with low gastric cancer incidence, address potential causes of cohort heterogeneity, and explore functional implications of genetic variation at the TLR1/6/10 locus. Methods: The dichotomous GWAS (25% individuals exhibiting highest anti–H pylori IgG titers vs remaining 75%) included discovery and replication sampls of, respectively, n = 15,685 and n = 9676, all of European ancestry. Longitudinal analysis of serologic data was performed on H pylori–eradicated subjects (n = 132) and patients under surveillance for premalignant gastric lesions (n = 107). TLR1/6/10 surface expression, TLR1 mRNA, and cytokine levels were measured in leukocyte subsets of healthy subjects (n = 26) genotyped for TLR1/6/10 variants. Results: The association of the TLR1/6/10 locus with anti–H pylori IgG titers (rs12233670; β = −0.267 ± SE 0.034; P = 4.42 × 10−15) presented with high heterogeneity and failed replication. Anti–H pylori IgG titers declined within 2–4 years after eradication treatment (P = 0.004), and decreased over time in patients with premalignant gastric lesions (P < 0.001). Variation at the TLR1/6/10 locus affected TLR1-mediated cytokine production and TLR1 surface expression on monocytes (P = 0.016) and neutrophils (P = 0.030), but not mRNA levels. Conclusions: The association between anti–H pylori IgG titers and TLR1/6/10 locus was not replicated across cohorts, possibly owing to dependency of anti–H pylori IgG titers on therapy, clearance, and antibody decay. H pylori–mediated immune cell activation is partly mediated via TLR1 signaling, which in turn is affected by genetic variation.
AB - Background & Aims: A genome-wide significant association between anti–Helicobacter pylori (H pylori) IgG titers and Toll-like receptor (TLR1/6/10) locus on 4p14 was demonstrated for individuals of European ancestry, but not uniformly replicated. We re-investigated this association in an updated genome-wide association study (GWAS) meta-analysis for populations with low gastric cancer incidence, address potential causes of cohort heterogeneity, and explore functional implications of genetic variation at the TLR1/6/10 locus. Methods: The dichotomous GWAS (25% individuals exhibiting highest anti–H pylori IgG titers vs remaining 75%) included discovery and replication sampls of, respectively, n = 15,685 and n = 9676, all of European ancestry. Longitudinal analysis of serologic data was performed on H pylori–eradicated subjects (n = 132) and patients under surveillance for premalignant gastric lesions (n = 107). TLR1/6/10 surface expression, TLR1 mRNA, and cytokine levels were measured in leukocyte subsets of healthy subjects (n = 26) genotyped for TLR1/6/10 variants. Results: The association of the TLR1/6/10 locus with anti–H pylori IgG titers (rs12233670; β = −0.267 ± SE 0.034; P = 4.42 × 10−15) presented with high heterogeneity and failed replication. Anti–H pylori IgG titers declined within 2–4 years after eradication treatment (P = 0.004), and decreased over time in patients with premalignant gastric lesions (P < 0.001). Variation at the TLR1/6/10 locus affected TLR1-mediated cytokine production and TLR1 surface expression on monocytes (P = 0.016) and neutrophils (P = 0.030), but not mRNA levels. Conclusions: The association between anti–H pylori IgG titers and TLR1/6/10 locus was not replicated across cohorts, possibly owing to dependency of anti–H pylori IgG titers on therapy, clearance, and antibody decay. H pylori–mediated immune cell activation is partly mediated via TLR1 signaling, which in turn is affected by genetic variation.
KW - Bacteria
KW - Immunity
KW - Serology
KW - Single-Nucleotide Polymorphism
KW - Genome-Wide Association Study
KW - Toll-Like Receptor 1/genetics
KW - Stomach Neoplasms/genetics
KW - Humans
KW - Immunoglobulin G
KW - Antibodies, Bacterial
KW - Helicobacter pylori
KW - Cytokines/genetics
KW - Helicobacter Infections/diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85128661221&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/eb2a9463-da5b-3ff5-bf8a-bfe75e8cb875/
U2 - 10.1053/j.gastro.2022.01.011
DO - 10.1053/j.gastro.2022.01.011
M3 - Article
C2 - 35031300
AN - SCOPUS:85128661221
SN - 0016-5085
VL - 162
SP - 1705
EP - 1715
JO - Gastroenterology
JF - Gastroenterology
IS - 6
ER -